nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Loperamide—Tamoxifen—pancreatic cancer	0.0803	0.202	CrCrCtD
Fentanyl—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0659	0.166	CrCrCtD
Fentanyl—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0659	0.166	CrCrCtD
Fentanyl—Methadone—Tamoxifen—pancreatic cancer	0.0551	0.139	CrCrCtD
Fentanyl—Benzphetamine—Tamoxifen—pancreatic cancer	0.0461	0.116	CrCrCtD
Fentanyl—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0427	0.108	CrCrCtD
Fentanyl—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0409	0.103	CrCrCtD
Fentanyl—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0316	0.0816	CbGbCtD
Fentanyl—CYP3A7—Tamoxifen—pancreatic cancer	0.0316	0.0816	CbGbCtD
Fentanyl—CYP3A7—Irinotecan—pancreatic cancer	0.0243	0.0626	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0243	0.0626	CbGbCtD
Fentanyl—CYP3A5—Tamoxifen—pancreatic cancer	0.0237	0.0612	CbGbCtD
Fentanyl—CYP3A5—Erlotinib—pancreatic cancer	0.0201	0.052	CbGbCtD
Fentanyl—CYP3A5—Irinotecan—pancreatic cancer	0.0182	0.047	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0178	0.0459	CbGbCtD
Fentanyl—CYP3A7—Docetaxel—pancreatic cancer	0.0178	0.0459	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0177	0.0457	CbGbCtD
Fentanyl—CYP3A7—Sunitinib—pancreatic cancer	0.0177	0.0457	CbGbCtD
Fentanyl—ABCB1—Tamoxifen—pancreatic cancer	0.0154	0.0398	CbGbCtD
Fentanyl—CYP3A5—Docetaxel—pancreatic cancer	0.0133	0.0344	CbGbCtD
Fentanyl—ABCB1—Gemcitabine—pancreatic cancer	0.0133	0.0343	CbGbCtD
Fentanyl—CYP3A5—Sunitinib—pancreatic cancer	0.0133	0.0343	CbGbCtD
Fentanyl—ABCB1—Erlotinib—pancreatic cancer	0.0131	0.0339	CbGbCtD
Fentanyl—ABCB1—Irinotecan—pancreatic cancer	0.0118	0.0306	CbGbCtD
Fentanyl—CYP3A4—Tamoxifen—pancreatic cancer	0.00924	0.0239	CbGbCtD
Fentanyl—ABCB1—Docetaxel—pancreatic cancer	0.00868	0.0224	CbGbCtD
Fentanyl—ABCB1—Sunitinib—pancreatic cancer	0.00864	0.0223	CbGbCtD
Fentanyl—CYP3A4—Erlotinib—pancreatic cancer	0.00786	0.0203	CbGbCtD
Fentanyl—CYP3A4—Irinotecan—pancreatic cancer	0.0071	0.0183	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—pancreatic cancer	0.00647	0.0167	CbGbCtD
Fentanyl—CYP3A4—Docetaxel—pancreatic cancer	0.0052	0.0134	CbGbCtD
Fentanyl—CYP3A4—Sunitinib—pancreatic cancer	0.00518	0.0134	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—pancreatic cancer	0.00388	0.01	CbGbCtD
Fentanyl—Weight decreased—Doxorubicin—pancreatic cancer	4.69e-05	0.000266	CcSEcCtD
Fentanyl—Sinusitis—Epirubicin—pancreatic cancer	4.68e-05	0.000265	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.67e-05	0.000265	CcSEcCtD
Fentanyl—Diarrhoea—Irinotecan—pancreatic cancer	4.67e-05	0.000265	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—pancreatic cancer	4.65e-05	0.000263	CcSEcCtD
Fentanyl—Shock—Docetaxel—pancreatic cancer	4.64e-05	0.000263	CcSEcCtD
Fentanyl—Nervous system disorder—Docetaxel—pancreatic cancer	4.63e-05	0.000262	CcSEcCtD
Fentanyl—Pruritus—Fluorouracil—pancreatic cancer	4.63e-05	0.000262	CcSEcCtD
Fentanyl—Thrombocytopenia—Docetaxel—pancreatic cancer	4.62e-05	0.000262	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—pancreatic cancer	4.62e-05	0.000262	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—pancreatic cancer	4.62e-05	0.000262	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—pancreatic cancer	4.62e-05	0.000262	CcSEcCtD
Fentanyl—Tachycardia—Docetaxel—pancreatic cancer	4.61e-05	0.000261	CcSEcCtD
Fentanyl—Skin disorder—Docetaxel—pancreatic cancer	4.59e-05	0.00026	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	4.58e-05	0.000259	CcSEcCtD
Fentanyl—Bradycardia—Epirubicin—pancreatic cancer	4.56e-05	0.000258	CcSEcCtD
Fentanyl—Diarrhoea—Gemcitabine—pancreatic cancer	4.55e-05	0.000258	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—pancreatic cancer	4.54e-05	0.000257	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.53e-05	0.000257	CcSEcCtD
Fentanyl—Dizziness—Irinotecan—pancreatic cancer	4.52e-05	0.000256	CcSEcCtD
Fentanyl—Haemoglobin—Epirubicin—pancreatic cancer	4.5e-05	0.000255	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—pancreatic cancer	4.5e-05	0.000255	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—pancreatic cancer	4.5e-05	0.000255	CcSEcCtD
Fentanyl—Anorexia—Docetaxel—pancreatic cancer	4.5e-05	0.000255	CcSEcCtD
Fentanyl—Rhinitis—Epirubicin—pancreatic cancer	4.49e-05	0.000255	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—pancreatic cancer	4.49e-05	0.000254	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—pancreatic cancer	4.49e-05	0.000254	CcSEcCtD
Fentanyl—Haemorrhage—Epirubicin—pancreatic cancer	4.48e-05	0.000254	CcSEcCtD
Fentanyl—Diarrhoea—Fluorouracil—pancreatic cancer	4.48e-05	0.000254	CcSEcCtD
Fentanyl—Hypoaesthesia—Epirubicin—pancreatic cancer	4.46e-05	0.000253	CcSEcCtD
Fentanyl—Pharyngitis—Epirubicin—pancreatic cancer	4.45e-05	0.000252	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—pancreatic cancer	4.43e-05	0.000251	CcSEcCtD
Fentanyl—Urinary tract disorder—Epirubicin—pancreatic cancer	4.43e-05	0.000251	CcSEcCtD
Fentanyl—Oedema peripheral—Epirubicin—pancreatic cancer	4.42e-05	0.00025	CcSEcCtD
Fentanyl—Hypotension—Docetaxel—pancreatic cancer	4.41e-05	0.00025	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—pancreatic cancer	4.4e-05	0.00025	CcSEcCtD
Fentanyl—Connective tissue disorder—Epirubicin—pancreatic cancer	4.4e-05	0.000249	CcSEcCtD
Fentanyl—Urethral disorder—Epirubicin—pancreatic cancer	4.39e-05	0.000249	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.37e-05	0.000247	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—pancreatic cancer	4.36e-05	0.000247	CcSEcCtD
Fentanyl—Vomiting—Irinotecan—pancreatic cancer	4.34e-05	0.000246	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—pancreatic cancer	4.33e-05	0.000246	CcSEcCtD
Fentanyl—Dizziness—Fluorouracil—pancreatic cancer	4.33e-05	0.000245	CcSEcCtD
Fentanyl—Visual impairment—Epirubicin—pancreatic cancer	4.32e-05	0.000245	CcSEcCtD
Fentanyl—Rash—Irinotecan—pancreatic cancer	4.31e-05	0.000244	CcSEcCtD
Fentanyl—Dermatitis—Irinotecan—pancreatic cancer	4.3e-05	0.000244	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.3e-05	0.000244	CcSEcCtD
Fentanyl—Headache—Irinotecan—pancreatic cancer	4.28e-05	0.000242	CcSEcCtD
Fentanyl—Insomnia—Docetaxel—pancreatic cancer	4.27e-05	0.000242	CcSEcCtD
Fentanyl—Paraesthesia—Docetaxel—pancreatic cancer	4.24e-05	0.00024	CcSEcCtD
Fentanyl—Erythema multiforme—Epirubicin—pancreatic cancer	4.24e-05	0.00024	CcSEcCtD
Fentanyl—Vomiting—Gemcitabine—pancreatic cancer	4.23e-05	0.00024	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—pancreatic cancer	4.22e-05	0.000239	CcSEcCtD
Fentanyl—Dyspnoea—Docetaxel—pancreatic cancer	4.21e-05	0.000238	CcSEcCtD
Fentanyl—Somnolence—Docetaxel—pancreatic cancer	4.2e-05	0.000238	CcSEcCtD
Fentanyl—Rash—Gemcitabine—pancreatic cancer	4.19e-05	0.000238	CcSEcCtD
Fentanyl—Dermatitis—Gemcitabine—pancreatic cancer	4.19e-05	0.000237	CcSEcCtD
Fentanyl—Eye disorder—Epirubicin—pancreatic cancer	4.19e-05	0.000237	CcSEcCtD
Fentanyl—Tinnitus—Epirubicin—pancreatic cancer	4.18e-05	0.000237	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—pancreatic cancer	4.17e-05	0.000236	CcSEcCtD
Fentanyl—Headache—Gemcitabine—pancreatic cancer	4.17e-05	0.000236	CcSEcCtD
Fentanyl—Cardiac disorder—Epirubicin—pancreatic cancer	4.16e-05	0.000236	CcSEcCtD
Fentanyl—Flushing—Epirubicin—pancreatic cancer	4.16e-05	0.000236	CcSEcCtD
Fentanyl—Vomiting—Fluorouracil—pancreatic cancer	4.16e-05	0.000236	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—pancreatic cancer	4.16e-05	0.000236	CcSEcCtD
Fentanyl—Dyspepsia—Docetaxel—pancreatic cancer	4.16e-05	0.000235	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—pancreatic cancer	4.15e-05	0.000235	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—pancreatic cancer	4.13e-05	0.000234	CcSEcCtD
Fentanyl—Rash—Fluorouracil—pancreatic cancer	4.12e-05	0.000234	CcSEcCtD
Fentanyl—Dermatitis—Fluorouracil—pancreatic cancer	4.12e-05	0.000233	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—pancreatic cancer	4.12e-05	0.000233	CcSEcCtD
Fentanyl—Decreased appetite—Docetaxel—pancreatic cancer	4.1e-05	0.000232	CcSEcCtD
Fentanyl—Headache—Fluorouracil—pancreatic cancer	4.1e-05	0.000232	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—pancreatic cancer	4.1e-05	0.000232	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—pancreatic cancer	4.09e-05	0.000231	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.08e-05	0.000231	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—pancreatic cancer	4.08e-05	0.000231	CcSEcCtD
Fentanyl—Fatigue—Docetaxel—pancreatic cancer	4.07e-05	0.000231	CcSEcCtD
Fentanyl—Angiopathy—Epirubicin—pancreatic cancer	4.07e-05	0.00023	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—pancreatic cancer	4.07e-05	0.00023	CcSEcCtD
Fentanyl—Nausea—Irinotecan—pancreatic cancer	4.06e-05	0.00023	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—pancreatic cancer	4.05e-05	0.000229	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—pancreatic cancer	4.04e-05	0.000229	CcSEcCtD
Fentanyl—Pain—Docetaxel—pancreatic cancer	4.04e-05	0.000229	CcSEcCtD
Fentanyl—Constipation—Docetaxel—pancreatic cancer	4.04e-05	0.000229	CcSEcCtD
Fentanyl—Chills—Epirubicin—pancreatic cancer	4.02e-05	0.000228	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—pancreatic cancer	4e-05	0.000227	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—pancreatic cancer	4e-05	0.000226	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—pancreatic cancer	3.96e-05	0.000224	CcSEcCtD
Fentanyl—Nausea—Gemcitabine—pancreatic cancer	3.95e-05	0.000224	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—pancreatic cancer	3.93e-05	0.000222	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—pancreatic cancer	3.92e-05	0.000222	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—pancreatic cancer	3.9e-05	0.000221	CcSEcCtD
Fentanyl—Erythema—Epirubicin—pancreatic cancer	3.9e-05	0.000221	CcSEcCtD
Fentanyl—Feeling abnormal—Docetaxel—pancreatic cancer	3.89e-05	0.00022	CcSEcCtD
Fentanyl—Nausea—Fluorouracil—pancreatic cancer	3.89e-05	0.00022	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—pancreatic cancer	3.88e-05	0.00022	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—pancreatic cancer	3.87e-05	0.000219	CcSEcCtD
Fentanyl—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.86e-05	0.000219	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—pancreatic cancer	3.85e-05	0.000218	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—pancreatic cancer	3.85e-05	0.000218	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—pancreatic cancer	3.84e-05	0.000218	CcSEcCtD
Fentanyl—Tension—Epirubicin—pancreatic cancer	3.83e-05	0.000217	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—pancreatic cancer	3.82e-05	0.000216	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—pancreatic cancer	3.79e-05	0.000215	CcSEcCtD
Fentanyl—Back pain—Epirubicin—pancreatic cancer	3.77e-05	0.000214	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—pancreatic cancer	3.76e-05	0.000213	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—pancreatic cancer	3.75e-05	0.000212	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—pancreatic cancer	3.75e-05	0.000212	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—pancreatic cancer	3.74e-05	0.000212	CcSEcCtD
Fentanyl—Abdominal pain—Docetaxel—pancreatic cancer	3.73e-05	0.000211	CcSEcCtD
Fentanyl—Body temperature increased—Docetaxel—pancreatic cancer	3.73e-05	0.000211	CcSEcCtD
Fentanyl—Chills—Doxorubicin—pancreatic cancer	3.72e-05	0.000211	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—pancreatic cancer	3.7e-05	0.00021	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—pancreatic cancer	3.68e-05	0.000208	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—pancreatic cancer	3.66e-05	0.000208	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—pancreatic cancer	3.63e-05	0.000206	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—pancreatic cancer	3.62e-05	0.000205	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—pancreatic cancer	3.61e-05	0.000204	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—pancreatic cancer	3.61e-05	0.000204	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—pancreatic cancer	3.61e-05	0.000204	CcSEcCtD
Fentanyl—Agitation—Epirubicin—pancreatic cancer	3.59e-05	0.000203	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—pancreatic cancer	3.56e-05	0.000202	CcSEcCtD
Fentanyl—Tension—Doxorubicin—pancreatic cancer	3.54e-05	0.000201	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—pancreatic cancer	3.54e-05	0.0002	CcSEcCtD
Fentanyl—Malaise—Epirubicin—pancreatic cancer	3.52e-05	0.000199	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—pancreatic cancer	3.51e-05	0.000199	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—pancreatic cancer	3.51e-05	0.000199	CcSEcCtD
Fentanyl—Syncope—Epirubicin—pancreatic cancer	3.5e-05	0.000198	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—pancreatic cancer	3.49e-05	0.000198	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—pancreatic cancer	3.49e-05	0.000198	CcSEcCtD
Fentanyl—Hypersensitivity—Docetaxel—pancreatic cancer	3.48e-05	0.000197	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—pancreatic cancer	3.47e-05	0.000197	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—pancreatic cancer	3.45e-05	0.000195	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—pancreatic cancer	3.43e-05	0.000194	CcSEcCtD
Fentanyl—Cough—Epirubicin—pancreatic cancer	3.4e-05	0.000193	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—pancreatic cancer	3.4e-05	0.000193	CcSEcCtD
Fentanyl—Asthenia—Docetaxel—pancreatic cancer	3.39e-05	0.000192	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—pancreatic cancer	3.38e-05	0.000191	CcSEcCtD
Fentanyl—Hypertension—Epirubicin—pancreatic cancer	3.37e-05	0.000191	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.35e-05	0.00019	CcSEcCtD
Fentanyl—Pruritus—Docetaxel—pancreatic cancer	3.34e-05	0.000189	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—pancreatic cancer	3.34e-05	0.000189	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—pancreatic cancer	3.32e-05	0.000188	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—pancreatic cancer	3.32e-05	0.000188	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—pancreatic cancer	3.32e-05	0.000188	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—pancreatic cancer	3.32e-05	0.000188	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—pancreatic cancer	3.31e-05	0.000188	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.3e-05	0.000187	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—pancreatic cancer	3.28e-05	0.000186	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—pancreatic cancer	3.26e-05	0.000184	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—pancreatic cancer	3.25e-05	0.000184	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—pancreatic cancer	3.24e-05	0.000184	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—pancreatic cancer	3.24e-05	0.000183	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—pancreatic cancer	3.23e-05	0.000183	CcSEcCtD
Fentanyl—Diarrhoea—Docetaxel—pancreatic cancer	3.23e-05	0.000183	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—pancreatic cancer	3.21e-05	0.000182	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—pancreatic cancer	3.19e-05	0.000181	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—pancreatic cancer	3.18e-05	0.00018	CcSEcCtD
Fentanyl—Oedema—Epirubicin—pancreatic cancer	3.18e-05	0.00018	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—pancreatic cancer	3.17e-05	0.00018	CcSEcCtD
Fentanyl—Infection—Epirubicin—pancreatic cancer	3.16e-05	0.000179	CcSEcCtD
Fentanyl—Cough—Doxorubicin—pancreatic cancer	3.15e-05	0.000178	CcSEcCtD
Fentanyl—Shock—Epirubicin—pancreatic cancer	3.13e-05	0.000177	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—pancreatic cancer	3.13e-05	0.000177	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—pancreatic cancer	3.12e-05	0.000177	CcSEcCtD
Fentanyl—Dizziness—Docetaxel—pancreatic cancer	3.12e-05	0.000177	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—pancreatic cancer	3.12e-05	0.000177	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—pancreatic cancer	3.12e-05	0.000177	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—pancreatic cancer	3.11e-05	0.000176	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—pancreatic cancer	3.09e-05	0.000175	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—pancreatic cancer	3.08e-05	0.000174	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—pancreatic cancer	3.07e-05	0.000174	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—pancreatic cancer	3.07e-05	0.000174	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—pancreatic cancer	3.07e-05	0.000174	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—pancreatic cancer	3.06e-05	0.000173	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.05e-05	0.000173	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—pancreatic cancer	3.04e-05	0.000172	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—pancreatic cancer	3.04e-05	0.000172	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—pancreatic cancer	3.01e-05	0.00017	CcSEcCtD
Fentanyl—Vomiting—Docetaxel—pancreatic cancer	3e-05	0.00017	CcSEcCtD
Fentanyl—Rash—Docetaxel—pancreatic cancer	2.98e-05	0.000169	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—pancreatic cancer	2.98e-05	0.000169	CcSEcCtD
Fentanyl—Dermatitis—Docetaxel—pancreatic cancer	2.97e-05	0.000168	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—pancreatic cancer	2.97e-05	0.000168	CcSEcCtD
Fentanyl—Headache—Docetaxel—pancreatic cancer	2.96e-05	0.000168	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.95e-05	0.000167	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—pancreatic cancer	2.95e-05	0.000167	CcSEcCtD
Fentanyl—Infection—Doxorubicin—pancreatic cancer	2.93e-05	0.000166	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.9e-05	0.000164	CcSEcCtD
Fentanyl—Shock—Doxorubicin—pancreatic cancer	2.9e-05	0.000164	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—pancreatic cancer	2.89e-05	0.000164	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.88e-05	0.000163	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—pancreatic cancer	2.88e-05	0.000163	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—pancreatic cancer	2.88e-05	0.000163	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—pancreatic cancer	2.86e-05	0.000162	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—pancreatic cancer	2.86e-05	0.000162	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.85e-05	0.000161	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—pancreatic cancer	2.84e-05	0.000161	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—pancreatic cancer	2.83e-05	0.00016	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—pancreatic cancer	2.81e-05	0.000159	CcSEcCtD
Fentanyl—Nausea—Docetaxel—pancreatic cancer	2.8e-05	0.000159	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—pancreatic cancer	2.8e-05	0.000159	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—pancreatic cancer	2.77e-05	0.000157	CcSEcCtD
Fentanyl—Hypotension—Doxorubicin—pancreatic cancer	2.75e-05	0.000156	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.75e-05	0.000156	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—pancreatic cancer	2.75e-05	0.000156	CcSEcCtD
Fentanyl—Pain—Epirubicin—pancreatic cancer	2.72e-05	0.000154	CcSEcCtD
Fentanyl—Constipation—Epirubicin—pancreatic cancer	2.72e-05	0.000154	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.68e-05	0.000152	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—pancreatic cancer	2.66e-05	0.000151	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—pancreatic cancer	2.65e-05	0.00015	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—pancreatic cancer	2.63e-05	0.000149	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—pancreatic cancer	2.62e-05	0.000149	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—pancreatic cancer	2.62e-05	0.000148	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.6e-05	0.000147	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—pancreatic cancer	2.59e-05	0.000147	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—pancreatic cancer	2.56e-05	0.000145	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.54e-05	0.000144	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—pancreatic cancer	2.54e-05	0.000144	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—pancreatic cancer	2.53e-05	0.000143	CcSEcCtD
Fentanyl—Pain—Doxorubicin—pancreatic cancer	2.52e-05	0.000143	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—pancreatic cancer	2.52e-05	0.000143	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—pancreatic cancer	2.52e-05	0.000143	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—pancreatic cancer	2.52e-05	0.000143	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—pancreatic cancer	2.43e-05	0.000138	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.41e-05	0.000136	CcSEcCtD
Fentanyl—Hypersensitivity—Epirubicin—pancreatic cancer	2.35e-05	0.000133	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—pancreatic cancer	2.34e-05	0.000133	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—pancreatic cancer	2.33e-05	0.000132	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—pancreatic cancer	2.33e-05	0.000132	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—pancreatic cancer	2.28e-05	0.000129	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—pancreatic cancer	2.25e-05	0.000128	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—pancreatic cancer	2.18e-05	0.000123	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—pancreatic cancer	2.17e-05	0.000123	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—pancreatic cancer	2.11e-05	0.00012	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—pancreatic cancer	2.11e-05	0.000119	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—pancreatic cancer	2.08e-05	0.000118	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—pancreatic cancer	2.02e-05	0.000115	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—pancreatic cancer	2.02e-05	0.000114	CcSEcCtD
Fentanyl—Rash—Epirubicin—pancreatic cancer	2.01e-05	0.000114	CcSEcCtD
Fentanyl—Dermatitis—Epirubicin—pancreatic cancer	2.01e-05	0.000114	CcSEcCtD
Fentanyl—Headache—Epirubicin—pancreatic cancer	1.99e-05	0.000113	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—pancreatic cancer	1.95e-05	0.00011	CcSEcCtD
Fentanyl—Nausea—Epirubicin—pancreatic cancer	1.89e-05	0.000107	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—pancreatic cancer	1.87e-05	0.000106	CcSEcCtD
Fentanyl—Rash—Doxorubicin—pancreatic cancer	1.86e-05	0.000105	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—pancreatic cancer	1.86e-05	0.000105	CcSEcCtD
Fentanyl—Headache—Doxorubicin—pancreatic cancer	1.85e-05	0.000105	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	1.8e-05	0.000457	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	1.77e-05	0.00045	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	1.76e-05	0.000446	CbGpPWpGaD
Fentanyl—Nausea—Doxorubicin—pancreatic cancer	1.75e-05	9.91e-05	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	1.75e-05	0.000443	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.73e-05	0.000438	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	1.72e-05	0.000437	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.72e-05	0.000437	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GCG—pancreatic cancer	1.71e-05	0.000435	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.69e-05	0.000429	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SST—pancreatic cancer	1.69e-05	0.000428	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.68e-05	0.000427	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.67e-05	0.000423	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.66e-05	0.000422	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	1.65e-05	0.000419	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SHH—pancreatic cancer	1.64e-05	0.000417	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	1.64e-05	0.000417	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	1.63e-05	0.000415	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	1.63e-05	0.000414	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	1.62e-05	0.000412	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STK11—pancreatic cancer	1.61e-05	0.000409	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.6e-05	0.000407	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.56e-05	0.000396	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	1.56e-05	0.000395	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	1.56e-05	0.000395	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	1.56e-05	0.000395	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.54e-05	0.000392	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.51e-05	0.000384	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.51e-05	0.000383	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.51e-05	0.000382	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GCG—pancreatic cancer	1.5e-05	0.000381	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.46e-05	0.000371	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ARG2—pancreatic cancer	1.46e-05	0.00037	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.45e-05	0.000369	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	1.43e-05	0.000364	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SST—pancreatic cancer	1.42e-05	0.000362	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STK11—pancreatic cancer	1.41e-05	0.000358	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	1.41e-05	0.000358	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.41e-05	0.000357	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.4e-05	0.000354	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.4e-05	0.000354	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	1.39e-05	0.000354	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	1.39e-05	0.000352	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HES1—pancreatic cancer	1.38e-05	0.00035	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CD44—pancreatic cancer	1.36e-05	0.000346	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.36e-05	0.000346	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.36e-05	0.000345	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.34e-05	0.00034	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.33e-05	0.000337	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.32e-05	0.000335	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	1.31e-05	0.000334	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GCG—pancreatic cancer	1.31e-05	0.000331	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.28e-05	0.000324	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TYMP—pancreatic cancer	1.28e-05	0.000324	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.27e-05	0.000323	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.27e-05	0.000323	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GCG—pancreatic cancer	1.27e-05	0.000322	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	1.27e-05	0.000322	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.25e-05	0.000318	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.25e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	1.24e-05	0.000314	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.24e-05	0.000313	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—STK11—pancreatic cancer	1.23e-05	0.000312	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.22e-05	0.000311	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.22e-05	0.000311	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	1.21e-05	0.000307	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HES1—pancreatic cancer	1.21e-05	0.000307	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TERT—pancreatic cancer	1.21e-05	0.000306	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STK11—pancreatic cancer	1.19e-05	0.000303	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.17e-05	0.000296	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.16e-05	0.000294	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.16e-05	0.000293	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	1.15e-05	0.000293	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	1.15e-05	0.000292	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APOE—pancreatic cancer	1.13e-05	0.000286	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.12e-05	0.000285	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	1.11e-05	0.000282	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KDR—pancreatic cancer	1.1e-05	0.00028	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.08e-05	0.000273	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.06e-05	0.00027	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TERT—pancreatic cancer	1.06e-05	0.000269	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.06e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	1.05e-05	0.000266	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.05e-05	0.000265	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	1.04e-05	0.000264	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.04e-05	0.000263	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.03e-05	0.000263	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.03e-05	0.000261	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.03e-05	0.000261	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HES1—pancreatic cancer	1.02e-05	0.000259	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	1.02e-05	0.000258	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	1.02e-05	0.000258	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	1.01e-05	0.000257	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—DPYD—pancreatic cancer	1.01e-05	0.000257	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	1.01e-05	0.000256	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGF—pancreatic cancer	1.01e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOE—pancreatic cancer	9.88e-06	0.000251	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD44—pancreatic cancer	9.85e-06	0.00025	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.78e-06	0.000248	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—pancreatic cancer	9.68e-06	0.000246	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A2—pancreatic cancer	9.6e-06	0.000243	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GCG—pancreatic cancer	9.44e-06	0.00024	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	9.4e-06	0.000238	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	9.27e-06	0.000235	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	9.21e-06	0.000234	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	9.12e-06	0.000231	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ARG2—pancreatic cancer	8.99e-06	0.000228	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—pancreatic cancer	8.95e-06	0.000227	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	8.94e-06	0.000227	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	8.92e-06	0.000226	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	8.92e-06	0.000226	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—STK11—pancreatic cancer	8.88e-06	0.000225	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.86e-06	0.000225	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGF—pancreatic cancer	8.82e-06	0.000224	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	8.75e-06	0.000222	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.68e-06	0.00022	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—pancreatic cancer	8.59e-06	0.000218	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	8.56e-06	0.000217	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	8.53e-06	0.000217	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—pancreatic cancer	8.35e-06	0.000212	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—pancreatic cancer	8.18e-06	0.000208	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	8.13e-06	0.000206	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	8.04e-06	0.000204	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TYMP—pancreatic cancer	7.86e-06	0.000199	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	7.84e-06	0.000199	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	7.79e-06	0.000198	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	7.78e-06	0.000197	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.77e-06	0.000197	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	7.75e-06	0.000197	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	7.71e-06	0.000196	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	7.68e-06	0.000195	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TYMS—pancreatic cancer	7.64e-06	0.000194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	7.54e-06	0.000191	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	7.54e-06	0.000191	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	7.49e-06	0.00019	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—pancreatic cancer	7.48e-06	0.00019	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGF—pancreatic cancer	7.45e-06	0.000189	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	7.44e-06	0.000189	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD44—pancreatic cancer	7.43e-06	0.000189	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	7.24e-06	0.000184	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	7.17e-06	0.000182	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCG—pancreatic cancer	7.12e-06	0.000181	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.05e-06	0.000179	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	6.98e-06	0.000177	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	6.91e-06	0.000175	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	6.87e-06	0.000174	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	6.83e-06	0.000173	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	6.82e-06	0.000173	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	6.77e-06	0.000172	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	6.73e-06	0.000171	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—STK11—pancreatic cancer	6.7e-06	0.00017	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	6.63e-06	0.000168	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	6.57e-06	0.000167	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	6.57e-06	0.000167	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.56e-06	0.000167	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	6.52e-06	0.000166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	6.49e-06	0.000165	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	6.34e-06	0.000161	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.33e-06	0.000161	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	6.29e-06	0.000159	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SRC—pancreatic cancer	6.25e-06	0.000158	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.23e-06	0.000158	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—pancreatic cancer	6.21e-06	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	6.12e-06	0.000155	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	6.08e-06	0.000154	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	6.06e-06	0.000154	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	6.02e-06	0.000153	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	6.01e-06	0.000152	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.96e-06	0.000151	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	5.94e-06	0.000151	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	5.94e-06	0.000151	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.91e-06	0.00015	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	5.91e-06	0.00015	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—pancreatic cancer	5.89e-06	0.000149	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.78e-06	0.000147	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TYMS—pancreatic cancer	5.76e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	5.76e-06	0.000146	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	5.6e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—pancreatic cancer	5.6e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	5.58e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	5.55e-06	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	5.51e-06	0.00014	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SRC—pancreatic cancer	5.48e-06	0.000139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	5.47e-06	0.000139	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—pancreatic cancer	5.41e-06	0.000137	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	5.36e-06	0.000136	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	5.33e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	5.31e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	5.28e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	5.27e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	5.17e-06	0.000131	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	5.17e-06	0.000131	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—pancreatic cancer	5.13e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	5.12e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	5.02e-06	0.000127	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	4.99e-06	0.000127	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	4.93e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—pancreatic cancer	4.91e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	4.9e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.87e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	4.8e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	4.75e-06	0.000121	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—pancreatic cancer	4.69e-06	0.000119	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SRC—pancreatic cancer	4.63e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—pancreatic cancer	4.6e-06	0.000117	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD44—pancreatic cancer	4.58e-06	0.000116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	4.53e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	4.51e-06	0.000114	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	4.46e-06	0.000113	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	4.45e-06	0.000113	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	4.4e-06	0.000112	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCG—pancreatic cancer	4.39e-06	0.000111	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	4.29e-06	0.000109	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—pancreatic cancer	4.26e-06	0.000108	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.23e-06	0.000107	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	4.17e-06	0.000106	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—pancreatic cancer	4.15e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	4.14e-06	0.000105	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STK11—pancreatic cancer	4.13e-06	0.000105	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—pancreatic cancer	4.08e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	4.06e-06	0.000103	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—pancreatic cancer	4.03e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	3.88e-06	9.85e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	3.85e-06	9.78e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	3.83e-06	9.72e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.72e-06	9.43e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.71e-06	9.42e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	3.62e-06	9.19e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.55e-06	9.01e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.52e-06	8.93e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—pancreatic cancer	3.41e-06	8.64e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	3.4e-06	8.64e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	3.26e-06	8.27e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.24e-06	8.22e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.21e-06	8.15e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.96e-06	7.51e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—pancreatic cancer	2.89e-06	7.33e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	2.88e-06	7.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—pancreatic cancer	2.8e-06	7.11e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.62e-06	6.64e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.61e-06	6.61e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.51e-06	6.38e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.29e-06	5.81e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.14e-06	5.43e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2e-06	5.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.98e-06	5.02e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.98e-06	5.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.73e-06	4.38e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—pancreatic cancer	1.61e-06	4.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.22e-06	3.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.94e-07	2.52e-05	CbGpPWpGaD
